Trial Profile
Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis - a Multicenter Randomised Double-blind Clinical Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Leflunomide
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms AMARA
- 19 Mar 2021 Primary endpoint (ACR 50 - Part I of the Study - 50% improvement of ACR defined disease activity) has not been met as per results published in the Rheumatology.
- 19 Mar 2021 Results published in the Rheumatology
- 16 Jan 2013 Planned End Date changed from 1 Aug 2012 to 1 Dec 2014 as reported by ClinicalTrials.gov.